tirzepatide for mash hits two receptors. Semaglutide hits one. The liver feels the difference. Both drugs work in MASH. The question is whether the second receptor — GIP — adds meaningful hepatic benefit beyond Tirzepatide in metabolic dysfunction-associated steatotic

Biomarkers such as fasting glucose sensitivity, and genetic variants in GIPR (rs1800437) loci may provide context for how an individual's physiology responds to semaglutide dosing and duration

Stomach or bowel conditions, autoimmune disease and previous gastrointestinal surgery

Gestational diabetes Gestational Diabetes can develop during pregnancy

Still working at your own pace, increase your intensity and duration

Laboratory Specification Laboratory Preparation Reconstitute using sterile bacteriostatic water where applicable and under clean laboratory technique

Other Weight Loss Medications Injectable weight loss drugs like semaglutide and tirzepatide may be taking the world by storm, but they're not your only options if you're considering weight loss medications